JAMIE BUSH: Open Payments
NPI 1699289330 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 27 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $718
Food & beverage: $718
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $206 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Grifols USA, LLC | 2 | $50 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $49 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Baxter Healthcare | 1 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Liquidia Technologies, Inc. | 1 | $32 |
| Verona Pharma, Inc. | 1 | $31 |
Products named: DUPIXENT, TEZSPIRE, Prolastin-C Liquid, LUMRYZ, NUCALA, Hillrom - Vest System Model 105 Home Care, JASCAYD, YUTREPIA.
Industry payments across PA — which companies pay providers there.
